Opus Genetics Board Director Secures 24,367 New Shares via Zero‑Cost RSU Grant, Signaling Insider Confidence in Rapidly‑Growing Biotech Firm
Opus Genetics insider buys 24,367 shares via RSUs, boosting confidence and aligning leadership with shareholders; investors eye potential upside amid strong recent rally.
3 minutes to read
